In this study, we have identified the CD14+low/CD68+low pMΦ subpopulation as that that undergoes changes in MΦ polarization in endometriosis, but further characterization of this subpopulation will be required before such targeted therapies could be trialled as a treatment for the disease. Here, CD14 is linked to endometriosis.